Tag: Alzheimer’s Disease

AriBio gets exclusive marketing rights in China for Alzheimer’s candidate AR1001 in $770m deal

businessnewstoday- March 25, 2024

In a significant stride towards addressing early Alzheimer’s disease, AriBio Co., Ltd. (AriBio) has announced an exclusive agreement to market AR1001, a pioneering investigational drug, ... Read More

Eisai invests $15m in C₂N Diagnostics to advance Alzheimer’s disease diagnostics

businessnewstoday- March 7, 2024

In a significant move for the field of brain health diagnostics, C₂N Diagnostics, LLC, a pioneer in developing advanced diagnostic solutions for Alzheimer's disease, has ... Read More

Alpha Cognition advances Alzheimer’s treatment with new patent filing

businessnewstoday- February 22, 2024

Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF), a pioneering biopharmaceutical company in the development of novel treatments for neurodegenerative diseases, has recently taken a significant ... Read More

Schroders Capital invests in Neurona Therapeutics to advance neural cell therapies

businessnewstoday- February 9, 2024

In a significant development for the life sciences sector, Schroders Capital Global Innovation Trust plc has announced a strategic investment of $1.6 million (£1.3 million) ... Read More

Biogen reprioritizes Alzheimer’s disease resources, discontinues ADUHELM development

businessnewstoday- January 31, 2024

Biogen Inc. (Nasdaq: BIIB), a leading pharmaceutical company, today announced a strategic reprioritization of its resources in Alzheimer’s disease (AD), a key therapeutic area expected ... Read More

Halozyme Therapeutics announces licensing deal with Acumen Pharmaceuticals for Alzheimer’s therapy advancement

businessnewstoday- November 6, 2023

Halozyme Therapeutics, Inc. has entered a pivotal global collaboration and non-exclusive licensing agreement with Acumen Pharmaceuticals. This partnership focuses on utilizing Halozyme's ENHANZE drug delivery ... Read More

Corium, Lotus Pharmaceutical seal deal for Alzheimer’s drug ADLARITY in Asia

businessnewstoday- August 13, 2023

Corium, a biopharmaceutical frontrunner in the neuroscience arena, and Lotus Pharmaceutical, a global pharmaceutical powerhouse, have declared a collaboration and license agreement. This pact centers ... Read More

Lilly’s donanemab shows encouraging results in Phase 3 Alzheimer’s trial

businessnewstoday- July 19, 2023

Eli Lilly and Company (Lilly) revealed complete results from its Phase 3 TRAILBLAZER-ALZ 2 study at the 2023 Alzheimer's Association International Conference (AAIC), indicating that ... Read More

Quanterix launches diagnostic test aiding early Alzheimer’s detection

businessnewstoday- July 9, 2023

Quanterix, a biomarker detection firm powering scientific research and breakthrough diagnostics, has introduced LucentAD, a new test designed to aid in the evaluation of patients ... Read More

Roche, Lilly team up to develop EAPP blood test for Alzheimer’s disease

businessnewstoday- March 22, 2023

Roche is teaming up with Eli Lilly and Company (Lilly) to support the development of its Elecsys Amyloid Plasma Panel (EAPP) blood test which has ... Read More